N@N

Stull, Stull & Brody Announces Investigation on Behalf of Participants and Beneficiaries of the GlaxoSmithKline Retirement Savi

^{Published on 2010-08-13 07:26:24 - Market Wire}
 

NEW YORK--([ BUSINESS WIRE ])--Attorney Advertising. Stull, Stull & Brody announced today that it has commenced an investigation relating to the 401(k) defined contribution retirement plan of GlaxoSmithKline plc (NYSE:GSK). Among other things, Stull, Stull & Brody is investigating whether fiduciaries of the GlaxoSmithKline 401(k) plan may have violated the Employee Retirement Income Security Act of 1974 (aERISAa) by failing to disclose the Companya™s true operating condition to participants and beneficiaries of the plans (including disclosures relating disclosures relating to the safety of Avandia, a diabetesdrug), by offering GlaxoSmithKline ADRs as an investment option under the plans when it was not prudent to do so, and/or by allowing an imprudent overconcentration of Company stock in the Companya™s 401(k) plans.

If you held GlaxoSmithKline stock in an individual account under any the Companya™s 401(k) plan or employee stock ownership plan you may, if you wish, consult with a representative of Stull, Stull & Brody at no cost or obligation. The contact information for Stull, Stull & Brody is as follows:

Stull, Stull & Brody has extensive experience in protecting the rights of 401(k) plan participants and beneficiaries and shareholders of public companies. Stull, Stull & Brody is presently representing classes of 401(k) plan participants in many class action cases throughout the country. Stull, Stull & Brody maintains offices in New York and Los Angeles.

Attorney Advertising. Prior Results Do Not Guarantee A Similar Outcome.